Case Details
- Citation: [2018] SGCA 87
- Case Number: Criminal Appeals No 38 and 39 of 2017
- Decision Date: 05 December 2018
- Court: Court of Appeal of the Republic of Singapore
- Coram: Sundaresh Menon CJ; Tay Yong Kwang JA; Chao Hick Tin SJ
- Judgment By: Sundaresh Menon CJ (majority consisting of Chao Hick Tin SJ and himself)
- Plaintiff/Applicant (Appellant): Mohamed Affandi bin Rosli
- Defendant/Respondent (Respondent): Public Prosecutor (and another appeal)
- Other Appellant: Mohamad Fadzli bin Ahmad
- Legal Areas: Criminal Law — Statutory offences; Criminal Procedure and Sentencing — Appeal; Evidence — Proof of evidence; Break in chain of evidence
- Statutes Referenced: Misuse of Drugs Act (Cap 185, 2008 Rev Ed) (“MDA”); Criminal Procedure Code (Cap 68, 2012 Rev Ed) (“CPC”); First Schedule to the MDA
- Key Provisions (as reflected in the extract): MDA ss 5(1)(a), 5(2), 8(a), 12, 33(1), 33B; MDA First Schedule (Class A controlled drug); CPC s 232(1)(b)
- Judicial History: Appeal from High Court decision in Public Prosecutor v Mohamad Fadzli bin Ahmad and another [2017] SGHC 233
- Counsel: Chia Soo Michael and Hany Soh Hui Bin (MSC Law Corporation) and Sankar s/o Kailasa Thevar Saminathan (Sterling Law Corporation) for the appellant in Criminal Appeal No 38 of 2017; Ramesh Chandr Tiwary (Messrs Ramesh Tiwary) and Luo Ling Ling (RHTLaw Taylor Wessing LLP) for the appellant in Criminal Appeal No 39 of 2017; Tan Wen Hsien and Carene Poh (Attorney-General’s Chambers) for the respondent
- Judgment Length: 42 pages, 24,484 words
Summary
Mohamed Affandi bin Rosli v Public Prosecutor and another appeal [2018] SGCA 87 concerned two appellants convicted of capital and related drug offences arising from a coordinated operation by the Central Narcotics Bureau (CNB) on 12 July 2013. Affandi was convicted of possession of not less than 132.82g of diamorphine for the purpose of trafficking (a Class A controlled drug), an offence under s 5(1)(a) read with s 5(2) of the Misuse of Drugs Act (MDA). His co-accused, Mohamad Fadzli bin Ahmad, was convicted of abetting by instigating Affandi to traffic in the same quantity of diamorphine (under s 5(1)(a) read with s 5(2) and s 12 of the MDA). Both offences attracted the mandatory death penalty.
The Court of Appeal addressed, among other matters, whether the prosecution proved the charge beyond reasonable doubt, including evidential issues relating to the integrity of the chain of custody and the reliability of statements recorded by CNB officers. The appeal also required the court to consider how appellate review should be conducted in capital drug cases, where the consequences of error are uniquely severe and where the evidential safeguards are correspondingly important.
What Were the Facts of This Case?
At the material time, Affandi worked as a fire safety supervisor at Marina Bay Sands (“MBS”). He lived at Block 124, Pasir Ris Street 11, and was the registered owner of a vehicle bearing registration number SJW 9386 M (“Affandi’s car”). Fadzli was a part-time mover who lived with his sister at Block 498L, Tampines Street 45 (“Fadzli’s flat”). He had charge of a vehicle bearing registration number SGW 4282 Y (“Fadzli’s car”). The CNB operation involved surveillance of Affandi and coordinated observation of the movements of both men and their vehicles.
On 12 July 2013, at about 7.45am, Affandi was seen getting on a motorcycle with another person, later identified as Mansor bin Mohamad Yusoff (“Mansor”), at the carpark of Affandi’s block. They rode off and later, at about 8.10am, entered the basement carpark of MBS. CNB officers had earlier noted that Affandi’s car was parked at basement 4M of the same carpark and positioned themselves in the vicinity.
Later that day, at about 3.18pm, Fadzli left his flat and drove off. At about 3.50pm, his car entered the MBS carpark and proceeded to basement 4M. Fadzli parked near Affandi’s car, alighted, and met Affandi behind Affandi’s car. Shortly thereafter, Fadzli returned to his car and drove out of the MBS carpark. These movements were significant because they placed both accused in close proximity at the relevant location and time, supporting the prosecution’s theory of a coordinated drug transaction.
At about 4pm, CNB officers intercepted Fadzli’s car and arrested Fadzli. They escorted Fadzli and his car to an open space nearby. At about 4.22pm, a search was conducted. The items recovered included plastic packets containing crystalline substances (marked as D1A and related sub-exhibits), a packet marked C1, and several plastic bags of groceries. The search of Fadzli’s car ended at about 4.45pm. Between about 4.50pm and 5pm, CNB recorded a statement from Fadzli in a CNB operational vehicle (P106A). At about 5.15pm, Fadzli was escorted to his flat, and at about 5.55pm, a search of the unit was conducted. Fadzli surrendered packets containing Erimin-5 tablets (nimetazepam). A further statement (P106B) was recorded between about 6.50pm and 6.55pm. At about 7.22pm, Fadzli was escorted to Woodlands Checkpoint for K-9 and backscatter searches on his car, and nothing incriminating was found.
Meanwhile, shortly after Fadzli’s arrest, at about 4.10pm, CNB arrested Affandi at his workplace at the MBS Fire Command Centre. Nothing incriminating was found at his work station or in two lockers at work. At about 5.18pm, Affandi was escorted to his car in the MBS carpark. A search was conducted and the exhibits relevant to the capital charges were found: eight bundles wrapped in black tape (marked B1 to B8) from under the last row of passenger seats, and additional packets of crystalline substances from the middle row of seats. A contemporaneous statement (P105) was recorded from Affandi at about 6.03pm in a CNB operational vehicle. After the statement, Affandi was escorted to Woodlands Checkpoint for K-9 and backscatter searches on his car, and nothing incriminating was found. He was then escorted to his flat, and again nothing incriminating was found. Affandi remained in CNB custody.
What Were the Key Legal Issues?
The principal legal issues in the appeal concerned whether the prosecution proved, beyond reasonable doubt, the elements of the two remaining capital charges: (i) Affandi’s possession of diamorphine for the purpose of trafficking (Charge E), and (ii) Fadzli’s abetting by instigating Affandi to traffic in that diamorphine (Charge A). Because these offences carry the mandatory death penalty, the court required strict compliance with evidential principles and careful scrutiny of the prosecution’s proof.
A second cluster of issues related to evidence and proof, particularly the integrity of the chain of evidence for the seized diamorphine and the reliability and admissibility of statements recorded by CNB officers. The extract indicates that the case involved arguments about “break in chain of evidence” and the “proof of evidence” framework. In drug cases, where the identity and quantity of the controlled drug are determinative, any material gap in the handling, identification, or documentation of exhibits can undermine the prosecution’s case.
Finally, the appeal required the Court of Appeal to consider how to treat the procedural history below. The High Court convicted both accused on some charges and acquitted them on others; the prosecution then obtained discharges not amounting to acquittal for certain non-capital charges. The appellate court therefore had to focus on the remaining charges that were still live and determine whether the convictions should be sustained.
How Did the Court Analyse the Issues?
The Court of Appeal began by setting out the structure of the prosecution case and the statutory framework. Affandi’s capital charge was framed under s 5(1)(a) read with s 5(2) of the MDA, which criminalises possession of a controlled drug for the purpose of trafficking, and the quantity threshold for the mandatory death penalty was engaged because the diamorphine seized was not less than 132.82g. Fadzli’s capital charge was framed as abetment by instigating Affandi to be in possession for the purpose of trafficking, relying on s 12 of the MDA in conjunction with s 5(1)(a) and s 5(2). The court’s analysis therefore necessarily involved both the factual question of possession and the legal question of whether the abetment element was proved.
On the evidential side, the court relied on the Health Sciences Authority (HSA) certificates confirming the identity and quantity of the seized substances. The HSA analysis found that the eight exhibits wrapped in black tape from Affandi’s car contained 132.82g of diamorphine. This finding was central: in capital drug cases, the prosecution must prove not only that the accused possessed a controlled drug, but also that the quantity meets the statutory threshold. The court treated the HSA certification as a key anchor for the prosecution’s proof, subject to the overarching requirement that the exhibits tested by HSA were the same exhibits seized from the accused.
The extract also points to a significant evidential dispute: whether there was a break in the chain of evidence. In Singapore jurisprudence, the chain of evidence doctrine requires the prosecution to show that the exhibits were properly identified, preserved, and transferred so that the court can be confident that the drug analysed by HSA is the same drug seized. Where there are gaps—such as missing documentation, unexplained handling, or inconsistencies in exhibit marking—an accused may argue that the prosecution has failed to prove the identity of the drug beyond reasonable doubt. The Court of Appeal’s majority reasoning (as reflected in the judgment’s focus) indicates that it scrutinised the handling of the diamorphine exhibits and the evidential steps taken by CNB officers.
Another important aspect of the analysis concerned the statements recorded by CNB officers. The extract notes that, during investigations, CNB recorded one contemporaneous statement from Affandi (P105) and two-part statements from Fadzli (P106A and P106B), as well as cautioned statements and Q1/Q2 style questioning. The court would have assessed whether these statements supported the prosecution’s theory that the diamorphine belonged to a third party and that Affandi’s possession was linked to trafficking. The Q&A excerpt shown in the prompt illustrates that Fadzli, when questioned about the eight black bundles, indicated that they belonged to a friend “Abut” and that he only knew the substance was called “Panas”, and that the bundles were stored in his car. Such statements, if properly admissible and reliable, can be relevant to the question of possession, knowledge, and the involvement of the accused in the trafficking scheme.
In addition, the Court of Appeal would have considered the legal standards applicable to appellate review of criminal convictions. While appellate courts generally defer to trial judges on matters of credibility and factual findings, the Court of Appeal in capital cases remains vigilant to ensure that the legal burden of proof has been met. Where the trial judge’s reasoning depends on evidential inferences drawn from statements and exhibit handling, the appellate court must verify that those inferences are logically sound and supported by the record.
Finally, the court’s analysis would have addressed the abetment charge against Fadzli. Abetment by instigating requires proof that the accused intentionally encouraged or caused another person to commit the principal offence. In the context of drug trafficking, this often turns on circumstantial evidence: the accused’s presence at the relevant location, coordination with the principal offender, and any admissions or statements indicating knowledge of the drug and its purpose. The court’s reasoning would have integrated the surveillance observations, the timing of arrests, the proximity of the accused to the seized diamorphine, and the content of statements to determine whether the instigation element was proved beyond reasonable doubt.
What Was the Outcome?
Applying its analysis to the record, the Court of Appeal upheld the convictions on the remaining capital charges. The majority judgment affirmed that the prosecution had proved the elements of Affandi’s possession for the purpose of trafficking of not less than 132.82g of diamorphine, and that Fadzli’s conduct amounted to abetting by instigating Affandi to traffic in the same quantity of diamorphine. The mandatory death penalty consequences therefore remained engaged for those convictions.
Practically, the outcome meant that the appellants’ attempts to overturn the High Court’s findings on proof and evidential integrity did not succeed. The convictions stood, and the case reinforced the high evidential standards expected in capital drug prosecutions, particularly regarding exhibit identity and the reliability of statements.
Why Does This Case Matter?
Mohamed Affandi bin Rosli v Public Prosecutor and another appeal [2018] SGCA 87 is significant for practitioners because it illustrates how the Court of Appeal approaches capital drug appeals where the prosecution’s case depends on both physical exhibits and statements recorded during CNB investigations. The case underscores that the identity and quantity of the controlled drug must be proven beyond reasonable doubt, and that arguments about breaks in the chain of evidence will be assessed with close attention to the factual record of exhibit handling and documentation.
For defence counsel, the case is a reminder that evidential challenges must be anchored in concrete gaps or inconsistencies in the prosecution’s handling of exhibits and the admissibility and reliability of statements. For prosecutors, it demonstrates the importance of meticulous exhibit marking, custody documentation, and careful recording of statements in a manner that can withstand appellate scrutiny.
More broadly, the decision contributes to the body of Singapore appellate jurisprudence on the proof of drug offences under the MDA and on the evidential framework for capital cases. It also reflects the court’s willingness to engage with both factual and legal issues—possession, trafficking purpose, and abetment—within a structured statutory analysis.
Legislation Referenced
- Misuse of Drugs Act (Cap 185, 2008 Rev Ed): ss 5(1)(a), 5(2), 8(a), 12, 33(1), 33B; First Schedule (Class A controlled drug)
- Criminal Procedure Code (Cap 68, 2012 Rev Ed): s 232(1)(b)
Cases Cited
- [2003] SGHC 60
- [2012] SGCA 18
- [2015] SGCA 33
- [2017] SGHC 233
- [2018] SGCA 59
- [2018] SGCA 87
Source Documents
This article analyses [2018] SGCA 87 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.